Article
MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer.
Molecular cancer - 14 Sept 2021
Li Haichang, Lin Pei-Hui, Gupta Pranav, Li Xiangguang, Zhao Serena Li, Zhou Xinyu, Li Zhongguang, Wei Shengcai, Xu Li, Han Renzhi, Lu Jing, Tan Tao, Yang Dong-Hua, Chen Zhe-Sheng, Pawlik Timothy M, Merritt Robert E, Ma Jianjie
Abstract excerpt
BACKGROUND: Cancer cells develop resistance to chemotherapeutic intervention by excessive formation of stress granules (SGs), which are modulated by an oncogenic protein G3BP2. Selective control of G3BP2/SG signaling is a potential means to treat non-small cell lung cancer (NSCLC). METHODS: Co-immunoprecipitation was conducted to identify the interaction of MG53 and G3BP2. Immunohistochemistry and live cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
